Cancer discovery symposium set for March 17

On March 17, the newly established Forbes Institute for Cancer Discovery will present its inaugural symposium in Ann Arbor, co-sponsored by the A. Alfred Taubman Medical Research Institute.

Four eminent speakers will discuss their latest findings in the understanding of cancer metabolism and how new research is leading to new avenues for cancer therapy.  

Speakers include Michael Lisanti, MD, PhD, Chair in Translational Medicine at the University of Salford (UK); Michael Pollak, MD, Alexander-Goldfarb Research Chair in Medical Oncology, McGill University; Max Wicha, MD, Director of the Forbes Institute for Cancer Discovery, University of Michigan, and Costas Lyssiotis, PhD, Assistant Professor of Molecular and Integrative Physiology, University of Michigan. Opening remarks by Eric Fearon, MD, PhD, Director of the University of Michigan Comprehensive Cancer Center.

All welcome, no registration required. Coffee and networking at 8:00 a.m. in the lobby of the A. Alfred Taubman Biomedical Science Research Building at 109 Zina Pitcher Place, Ann Arbor, MI, 48170. 

The Forbes Institute, established in 2016 with a gift from noted Michigan philanthropists Madeline and Sidney Forbes, aims to accelerate the translation of cutting-edge cancer treatment from the laboratory to patients.  It is lead by Dr. Wicha, a Founding Taubman Scholar who established the U-M Compreshensive Cancer Center. 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift